Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659718 · ClinicalTrials.gov registry record
Emulation of the SOUL Diabetes Trial in Healthcare Claims
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 43,650
- Enrollment target
NCT06659718: Completed study, sponsored by Brigham and Women's Hospital.
NCT06659718 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 43,650 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06659718 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 43,650 participants
- Enrollment target
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Primary Outcome
Hazard ratio
Interventions
- DRUG Sitagliptin
- DRUG Oral semaglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43,650 participants |
| Start Date | 2024-10-24 |
| Est. Completion | 2025-02-13 |
What the finished NCT06659718 record still lists
NCT06659718 is an observational study that tracks outcomes without assigning an intervention. Its 43,650 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Sitagliptin is the first listed.
NCT06659718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06659718 about?
NCT06659718 is a clinical study titled "Emulation of the SOUL Diabetes Trial in Healthcare Claims". Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such s...
What is the current status of trial NCT06659718?
This trial is currently completed. The enrollment target is 43,650 participants. The study started on 2024-10-24. Estimated completion is 2025-02-13.
What interventions are being tested in trial NCT06659718?
The interventions under investigation include: Sitagliptin (DRUG), Oral semaglutide (DRUG).
Who is sponsoring clinical trial NCT06659718?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI